|
(P359) |
Changes over time in the implementation of sacubitril/valsartan and concomitant use of SGLT2 inhibitors in HFrEF patients: real world insights from Germany |
| |
|
S. Störk, U. Riemer, R. Wachter, M. Böhm, M. Schulz (Würzburg, Nürnberg, Leipzig, Homburg/Saar, Berlin) |
|
(P360) |
Association of leptin and pericardial adipose tissue in the clinical improvement of heart failure patients during treatment with sacubitril/valsartan |
| |
|
Z. Shomanova, B. Ohnewein, P. Jirak, V. van Almsick, J. Sindermann, M.-C. Brandt, C. Granitz, U. C. Hoppe, M. Lichtenauer, H. Reinecke, L. J. Motloch, R. Pistulli (Münster; Salzburg, AT) |
|
(P361) |
Efficacy of Ivabradine in High-risk Heart Failure Patients (Sub-anaylsis from the SHIFT Trial) |
| |
|
A. Abdin, M. Komajda, J. S.Borer, I. Elyubaewa, I. Ford, L. Tavazzi, K. Swedberg, M. Böhm (Homburg/Saar; Paris, Suresnes Cedex, FR; NY, US; Glasgow, UK; Cotignola, IT; Göteborg, SE) |
|
(P362) |
Effects Of Multimorbidity On In-hospital Versus Post-discharge Drug Treatment Patterns In Patients Hospitalized With Acute Heart Failure |
| |
|
C. E. Angermann, C. Morbach, G. Güder, J. Albert, U. Stefenelli, S.-O. Tröbs, A. Stürmlinger, M. Hanke, N. Scholz, V. Cejka, S. Frantz, G. Ertl, S. Störk, für die Studiengruppe: AHF Registry (Würzburg, Ingelheim) |
|
(P363) |
Beta- blockers reduce Oxygen Pulse Increase and Performance in Heart Failure Patients with Preserved Ejection Fraction |
| |
|
S. Wernhart, M. Papathanasiou, A.-A. Mahabadi, T. Rassaf, P. Lüdike (Essen) |
|
(P365) |
Empagliflozin senkt den Interleukin-6-Spiegel bei Patienten mit Herzinsuffizienz |
| |
|
M. Gotzmann, P. Henk, A. Mügge, N. Babel, T. Westhoff (Bochum, Herne) |
|
(P366) |
Ein holistisches Medizinisches Outcome Modell von patientenrelevanten und Surrogat-Endpunkten in der Herzinsuffizienzversorgung: Ein erster Überblick |
| |
|
B. Steiner, A. Gingele, C. F. Ski, J. Brandts, M. Barrett, C. Watson, D. R. Thompson, M. Jacobsen, H. Amin, J. J. Boyne, Y. Pelz, M. Verket, T. M. Helms, H.-P. Brunner-La Rocca, B. Zippel-Schultz, für die Studiengruppe: PASSION-HF (Berlin, Maastricht, Aachen; Ipswich, Belfast, UK; Dublin, IE) |
|
(P367) |
Patient-reported outcomes in short-time follow-up after discharge of patients with advanced heart failure |
| |
|
T. Wagner, L. Zhou, C. Magnussen, P. Kirchhof, H. Grahn (Hamburg) |
|
(P368) |
Sacubitril/Valsartan improves survival and augments cardiac function after myocardial infarction through Notch1-dependent de-novo angiogenesis |
| |
|
E. Klapproth, G. Schlüter, A. Shukla, S. Künzel, K. Lorenz, K. Guan, A. El-Armouche (Dresden, Würzburg) |